Chemours (CC) PT Lowered to $19 at UBS
Tweet
Share
E-mail
Get Alerts CC Hot Sheet
Price: $15.26 +0.13%
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Rating Summary:
9 Buy, 9 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 9
Join SI Premium – FREE
UBS analyst John Roberts lowered the price target on Chemours (NYSE: CC) to $19.00 (from $21.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chemours (CC) PT Lowered to $15 at JPMorgan
- Ascendis Pharma (ASND) PT Raised to $333 at Jefferies
- Resideo Technologies (REZI) PT Lowered to $27 at Oppenheimer
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
UBSSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
